Pricing Log in Create free account

Bionano Genomics, Inc. (BNGO) vs Femasys Inc. (FEMY)

Bionano Genomics, Inc. and Femasys Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $16.1M against $14.5M — 1.1× the size. Femasys Inc. grew revenue faster over the last twelve months: 21.9% against 10.0%. Bionano Genomics, Inc. has the higher net margin (−106.6% vs −534.3%) and the higher return on invested capital (−81.7% vs −176.9%). Across the 18 metrics below, Bionano Genomics, Inc. leads on 14 and Femasys Inc. on 4.

Valuation

Metric BNGO FEMY Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 0.48 2.41 2.52
P/B 0.46 1.37 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 0.72 3.35 2.88
Earnings yield (241.60%) (213.94%) (2.67%)
Free cash flow yield (142.62%) (326.31%) 0.09%

Profitability

Metric BNGO FEMY Medical Instruments & Supplies median
Gross margin 47.51% 60.95% 54.29%
Operating margin (106.67%) (763.90%) 1.07%
Net margin (106.58%) (534.27%) (1.61%)
Free cash flow margin (67.87%) (786.02%) 1.08%
Return on equity (83.56%) (443.65%) (1.32%)
Return on assets (52.04%) (94.25%) 0.00%
Return on invested capital (81.68%) (176.91%) 0.00%

Growth

Metric BNGO FEMY Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% 21.85% 8.85%
EPS growth (last fiscal year) 94.50% 44.71% 8.65%
Revenue growth, 5-year CAGR 27.37% 17.18% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNGO FEMY Medical Instruments & Supplies median
Debt to equity 0.11 0.90 0.10
Current ratio 2.48 2.14 2.48
Net debt to EBITDA 1.06 0.23 0.89

Dividend

Metric BNGO FEMY Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric BNGO FEMY Medical Instruments & Supplies median
Market cap 16.13m 14.54m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack